Tonix Pharma (TNXP) Stock Statistics & Valuation Metrics

Tonix Pharma has a market cap or net worth of $171.49M. The enterprise value is -$37.01M.

Tonix Pharma has 12,788,069 shares outstanding. The number of shares has decreased by -2.65% in one year.

Tonix Pharma’s return on equity (ROE) is 0.00 and return on invested capital (ROIC) is 0.00%.

The current PE Ratio of Tonix Pharma is ―. Tonix Pharma’s PEG ratio is 0.00.

In the last 12 months, Tonix Pharma had revenue of 13.11M and earned 0.00 in profits. Earnings per share was -14.57.

In the last 12 months, operating cash flow was -99.84M and capital expenditures -5.38M, giving a free cash flow of -105.22M billion.

Tonix Pharma pays an annual dividend of ―, resulting in a dividend yield of ―

Tonix Pharma upcoming earnings date is May 11, 2026, TBA (Confirmed).

Tonix Pharma as a current ratio of 7.42, with Debt / Equity ratio of 0.53%

In the past 12 months, Tonix Pharma has paid 0.00 in taxes.

Tonix Pharma EV to EBITDA ratio is 0.58, with an EV/FCF ratio of 0.71.

Tonix Pharma has $207.64M in cash and marketable securities with $1.31M in debt, giving a net cash position of $206.33M billion.

Gross margin is 49.34%, with operating margin of -959.05%, and net profit margin of 0.00%.

The average price target for Tonix Pharma is $67.50, which is 11.43% higher than the current price. The consensus rating is Moderate Buy